ClaroNav, a company headquartered in Toronto, Canada, won FDA clearance for its NaviENT system that gives otolaryngologists information about the location of the tip of an instrument introduced during functional endoscopic sinus and skull base surgeries. During such surgeries, which are performed through the nose, the NaviENT shows the instrument tip superimposed on a 3D CT scan performed earlier on the same patient. This allows physicians to accurately traverse through difficult anatomy while avoiding fragile and important tissues.
The system uses 3D cameras placed not far from the head of the patient that follow optical tracking balls attached near the proximal ends of the instruments. Since the system knows the distance from the tracking balls to the instrument’s tip, it can quickly calculate the tip’s location and overlay it on the tomography scan.
The firm believes that outcomes can be significantly improved, leading to shortened hospital stays and more comfort and savings for everyone involved. “[NaviENT] is a precious aid in primary surgery and its benefits are widely accepted among neurosurgeons and otolaryngologists. Its 3D anatomical structure localization and visualization capability assists the surgeons to target specific anatomy and avoid complications in highly variable sinus anatomy. However, despite its obvious advantages, many surgeons are hesitant in adapting the technology, blaming its cumbersome operation and high price tag.” said Ahmad Kolahi, CEO of CKI “NaviENT is an innovative navigation system designed in close collaboration with experienced rhinologists to address shortcomings of the current navigation systems. Our primary goal is to offer an intuitive, accurate and affordable state-of-the-art ENT navigation system and make it standard-of-care in the ENT field.”
Here you can check out the software powering NaviENT:
Product page: NaviENT…
Via: ClaroNav…